Key facts
- It has raised $3.1M across 1 recorded rounds; the latest was Seed Round ($1.2M) in Oct 2021.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Metallomix
Funding rounds
1 roundsAbout Metallomix
Operator of a clinical-stage biotechnology platform designed to advance therapeutics that modulate metalloprotein-driven cellular pathways. The company offers a zinc-modulating drug candidate with a broad therapeutic profile, enabling healthcare providers to address diseases linked to dysregulated intracellular metal biology with targeted pharmacological interventions.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2015
- Employees
- 7
- Website
- metallomix.com/
- Ownership
- Privately Held (backing)
Metallomix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Metallomix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Metallomix in its N-PORT filings yet. We sweep new filings monthly.